Pages that link to "Item:Q2635012"
From MaRDI portal
The following pages link to Modeling the short time-scale dynamics of \(\beta\)-amyloid-neuron interactions (Q2635012):
Displaying 13 items.
- Modeling the interaction between \(\beta\)-amyloid aggregates and choline acetyltransferase activity and its relation with cholinergic dysfunction through two-enzyme/two-compartment model (Q278122) (← links)
- Scale-free neurodegeneration: cellular heterogeneity and the stretched exponential kinetics of cell death (Q781263) (← links)
- Exploring the mechanism of \(\beta\)-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models (Q1620791) (← links)
- Data-driven modeling of Alzheimer disease pathogenesis (Q1786817) (← links)
- In silico docking reveals possible riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy (Q1790872) (← links)
- A kinetic analysis of the mechanism of \(\beta\)-amyloid induced G protein activation (Q2177114) (← links)
- Dynamic analysis of synaptic loss and synaptic compensation in the process of associative memory ability decline in Alzheimer's disease (Q2243347) (← links)
- Modeling effect of a \(\gamma \)-secretase inhibitor on amyloid-\(\beta \) dynamics reveals significant role of an amyloid clearance mechanism (Q2430580) (← links)
- A qualitative model for aggregation and diffusion of \(\beta \)-amyloid in Alzheimer's disease (Q2435080) (← links)
- Why does \(\beta \)-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies (Q2459096) (← links)
- Modelling of calcium dynamics in brain energy metabolism and Alzheimer's disease (Q2500292) (← links)
- Modeling the spatial propagation of A<i>β</i> oligomers in Alzheimer’s Disease (Q3300108) (← links)
- Towards optimal control of amyloid fibrillation (Q6053050) (← links)
